in Vitro Immuno Therapy Assays
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
15
NCT01419691
Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)
Phase: Phase 2
Role: Collaborator
Start: Sep 30, 2011
Completion: Sep 30, 2015
Loading map...